Literature DB >> 22050200

Exercise-induced respiratory symptoms not due to asthma.

Chetan A Pandit1, Eugenie Batterby, Peter Van Asperen, Peter Cooper, Hiran Selvadurai, Dominic A Fitzgerald.   

Abstract

This manuscript describes two interesting patients who had exercise-induced symptoms that unmasked an alternative underlying diagnosis. The first is an 8-year-old boy who was treated for asthma all his life but really had exercise-induced stridor (labelled as wheeze) causing significant exercise limitation, which was due to a double aortic arch with the right arch compressing the trachea. The second case describes the diagnosis of vocal cord dysfunction in a 13-year-old anxious high achiever. He also initially had exercise-induced symptoms treated as exercise-induced wheeze but again had a stridor due to vocal cord dysfunction. Both these cases demonstrate the importance of detailed history including during exercise, which can unmask alternative diagnosis. Another important message is that if there is no response to bronchodilator treatment with absence of typical signs and symptoms of asthma, alternative diagnosis should be considered.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  exercise-induced stridor; vascular ring; vocal cord dysfunction

Mesh:

Year:  2011        PMID: 22050200     DOI: 10.1111/j.1440-1754.2011.02209.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Reduced Exercise Tolerance Does Not Always Mean Bronchial Asthma.

Authors:  Anna Porębska; Edyta Liszka; Henryk Mazurek
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09-23       Impact factor: 0.885

2.  Association between vascular rings and learning performance: A cross-sectional study.

Authors:  Fong-Lin Chen; Yung-Po Liaw; Shu-Yi Hsu; Oswald Ndi Nfor
Journal:  J Clin Ultrasound       Date:  2017-05-29       Impact factor: 0.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.